No, Merck’s Pill Won’t End the Pandemic
This undated image provided by Merck & Co. shows their new antiviral medication.
Here’s the latest news from the pandemic.
Merck’s Covid pill is ushering fresh optimism about the course of this seemingly endless pandemic. Early studies show the drug has the potential to cut the rate of hospitalization and death by around 50% in mild to moderate Covid patients.